Oncternal Therapeutics (ONCT) Financials

$0.53

$0.00 (0.00%)

As on 29-Apr-2025 09:30EDT

Market cap

$2 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	1.67	0.79	1.49	4.32	3.38	2.43
Cost of Revenue	18.63	29.75	0.18	0.17	12.00	10.16
Gross Profit	-16.96	-28.97	1.49	4.32	3.38	-7.73
Operating Expenses	37.63	12.75	44.95	31.37	17.54	15.02
Operating Profit (EBIT)	-35.96	-41.71	-44.95	-31.37	-17.54	-33.11
Other Income	--	--	0.79	--	0.32	-1.08
Profit before Tax	-34.58	-39.48	-44.17	-31.33	-17.23	-34.19
Provision for Tax	-27.28	-41.71	-0.78	-0.03	-0.02	-18.28
Profit after Tax (Net Income)	-34.58	-39.48	-43.39	-31.30	-17.21	-15.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-44.17	-31.33	-17.23	-34.19

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	9.15	30.05	-158.30	-114.13	-82.80	14.31
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	1.48	3.00	2.03	2.82	0.09
Current Liabilities	6.45	5.20	7.68	5.47	5.86	7.34
Total Liabilities	22.05	36.73	68.65	93.59	118.81	21.74

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.15	0.67	1.36	0.73	0.81	0.96
Current Assets	15.45	36.06	67.29	92.85	118.00	20.79
Total Assets	22.05	36.73	68.65	-108.67	-76.94	21.74
Total Debt*	0.19	0.32	0.09	0.08	0.04	0.19
Net Current Assets	8.99	30.86	59.61	87.39	112.15	13.45

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-32.16	-36.70	-26.59	-17.50	-16.75
Cash Flow from Investing Activities	--	--	-26.50	-26.50	-26.50	16.14
Cash from Financing Activities	--	1.07	9.58	0.62	114.18	0.02
Net Cash Inflow / Outflow	--	--	-53.62	--	96.69	-0.59

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-11.69	-13.39	-15.34	-0.63	-0.59	-1.04
Cash EPS ($)	--	-13.39	-15.34	-0.63	-0.59	-1.04
Adjusted Book Value ($)	--	10.19	--	--	--	0.93
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-10.91	-12.98	-0.54	-0.60	-1.09
Free Cash Flow per Share ($)	--	-10.91	-12.98	-0.54	-0.60	-1.09

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	61.76	31.88	31.81	50.43	-36.49
ROE (%)	-215.60	61.57	31.86	31.79	50.26	-78.73
ROA (%)	-98.22	-74.93	-53.49	-29.47	-24.49	-59.97
EBIT Margin (%)	-3,246.13	-5,029.17	-3,016.58	-726.91	-519.76	-1,984.66
Net Margin (%)	-2,074.09	-5,029.17	-1,906.55	-725.38	-466.12	-1,183.05
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	165.87	-0.47	-0.65	0.28	0.39	-0.04
EBIT Growth (%)	-23.94	12.17	-43.30	-78.81	63.55	-631.65
Net Profit Growth (%)	16.08	9.02	-38.64	-81.88	-8.15	58.58
EPS Growth (%)	17.49	0.13	-23.22	-0.08	0.44	0.91
Book Value Growth (%)	104.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.04	-0.07	-3.58	-8.37	-3.81
Price / Book Value	0.17	0.05	-0.02	-0.98	-1.74	4.24
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.15	-14.47	1.37	-0.69	-1.56	-1.23
Close Price ($)	1.32	10.80	20.00	45.40	98.00	79.00
High Price ($)	161.96	26.60	52.80	211.20	143.80	358.40
Low Price ($)	1.31	5.22	13.80	44.40	29.80	68.60
Market Cap ($ Cr)	1.56	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.01	0.00	0.00	0.00	0.01
Short term debt to equity ratio	0.02	0.01	0.00	0.00	0.00	0.01
Current Ratio	2.39	6.94	8.76	16.99	20.14	2.83
Quick Ratio	2.39	6.94	8.75	17.16	--	--
Interest Coverage	-4,320.88	--	-64.03	-950.48	-1,096.38	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	20.64	80.51	11.95	21.88	--	--
Asset Turnover	0.05	0.01	0.02	0.04	0.05	0.09
Receivable days	--	188.44	137.52	79.91	--	--
Inventory Days	--	0.63	-858.03	-2,040.21	--	--
Payable days	--	24.95	4,974.75	3,352.09	30.65	74.60
Cash Conversion Cycle	--	164.12	-5,695.26	-5,312.39	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.